FDA Plays Musical Chairs In Commissioner's Office: Hot Seat Remains Open
This article was originally published in The Gray Sheet
Executive Summary
The appointment of former FDA Office of Review Management Director Murray Lumpkin, MD, as acting deputy commissioner is part of an Office of the Commissioner restructuring plan announced Oct. 1.